Investor Says Endo Lied About Role In NY Opioid Crisis
By Jeannie O'Sullivan · June 22, 2020, 4:55 PM EDT
An Endo International PLC investor launched a proposed class action Monday claiming the drugmaker's stock dropped nearly 15% after allegations surfaced about the company's role in New York's opioid crisis, unearthing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login